Stock listing

NASDAQ:IGMS IGM Biosciences Inc Stock

Follow IGM Biosciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:IGMS

$1.27 USD

Close on Aug 13, 2025 · No longer trades

Sep 18, 2019 to last close -94.8% · weekly closes, Sep 18, 2019 – Aug 13, 2025
Lowest – highest close
$1.02 – $121.23 USDSince Sep 18, 2019 · lowest Apr 8, 2025 · highest Feb 9, 2021

Delisted NASDAQ:IGMS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:IGMS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

IGM Biosciences Inc on 6ix

Calls
2 calls with a replay · 2 with a transcript · latest Mar 30, 2023
Decks
2 decks · latest Jan 6, 2023

Events

CallWhenStatus
IGM Biosciences (IGMS) Q4 2022 Earnings CallThu, Mar 30, 2023 · 4:30 PM ETReplay
IGM Biosciences (IGMS) Q4 2020 Earnings CallTue, Mar 30, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2023)Investor deck37 slidesJan 6, 2023
Investor Presentation (December 2020)Investor deck39 slidesDec 7, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Felix Baker
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past)
Director · Since at least Sep 17, 2019
Chris H Takimoto
Other companies: ALX Oncology Holdings Inc. (Director · Since at least Jan 21, 2025); Forty Seven Inc (Chief Medical Officer · Jun 27, 2018 – Apr 7, 2020 · Past)
CHIEF MEDICAL OFFICER · Jul 30, 2021 – Sep 13, 2024 · Past
M. Kathleen Behrens
Other companies: MiMedx Group, Inc (Director · Since at least Jun 19, 2019); Sarepta Therapeutics, Inc. (Chairwoman · Since at least Mar 10, 2017)
Director · Since at least Sep 17, 2019
Elizabeth H Z Thompson
Other companies: ACADIA Pharmaceuticals Inc. (EVP, Head of Research & Dev · Since at least Apr 4, 2024)
Director · Since at least Oct 3, 2023
Lisa Lynn Decker
Other companies: Chimerix Inc (Director · Apr 21, 2025 – Apr 21, 2025 · Past)
CHIEF BUSINESS OFFICER · Since at least Jun 16, 2025
Michael D Loberg
Other companies: ArQule Inc (Director · May 13, 2013 – Jan 16, 2020 · Past)
Director · Sep 17, 2019 – Sep 29, 2023 · Past
Misbah Tahir
Other companies: Maze Therapeutics, Inc. (Chief Financial Officer · Since at least Sep 2, 2025)
CHIEF FINANCIAL OFFICER · Since at least Sep 17, 2019
Steven Weber
Other companies: Pulse Biosciences, Inc (Principal Accounting Officer · Since at least Jul 14, 2025)
PRINCIPAL ACCOUNTING OFFICER · Since at least May 25, 2022
Christina Teng TopsoeDirector · Since at least Sep 29, 2023
George GauthierChief Commercial Officer · Apr 16, 2021 – Nov 29, 2023 · Past
All 11 people
PersonSeat
Mary Beth HarlerChief Executive Officer, Director · Since at least Apr 14, 2024

Open People

Log in to ask 6ix AI your own questions about IGM Biosciences Inc.